300204 Stock Overview
Staidson (Beijing) BioPharmaceuticals Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.08 |
| 52 Week High | CN¥12.79 |
| 52 Week Low | CN¥5.41 |
| Beta | 0.50 |
| 11 Month Change | -2.65% |
| 3 Month Change | 26.25% |
| 1 Year Change | -32.78% |
| 33 Year Change | -62.38% |
| 5 Year Change | -21.40% |
| Change since IPO | 14.29% |
Recent News & Updates
Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SZSE:300204) Stock Rockets 47% As Investors Are Less Pessimistic Than Expected
Oct 08
Subdued Growth No Barrier To Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SZSE:300204) With Shares Advancing 26%
Aug 03There's Reason For Concern Over Staidson (Beijing) BioPharmaceuticals Co., Ltd.'s (SZSE:300204) Massive 26% Price Jump
Aug 02Recent updates
Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SZSE:300204) Stock Rockets 47% As Investors Are Less Pessimistic Than Expected
Oct 08Subdued Growth No Barrier To Staidson (Beijing) BioPharmaceuticals Co., Ltd. (SZSE:300204) With Shares Advancing 26%
Aug 03There's Reason For Concern Over Staidson (Beijing) BioPharmaceuticals Co., Ltd.'s (SZSE:300204) Massive 26% Price Jump
Aug 02What Staidson (Beijing) BioPharmaceuticals Co., Ltd.'s (SZSE:300204) 25% Share Price Gain Is Not Telling You
Mar 18Shareholder Returns
| 300204 | CN Biotechs | CN Market | |
|---|---|---|---|
| 7D | 0.4% | -0.8% | -0.9% |
| 1Y | -32.8% | -17.3% | 5.4% |
Return vs Industry: 300204 underperformed the CN Biotechs industry which returned -16.5% over the past year.
Return vs Market: 300204 underperformed the CN Market which returned 6.1% over the past year.
Price Volatility
| 300204 volatility | |
|---|---|
| 300204 Average Weekly Movement | 8.8% |
| Biotechs Industry Average Movement | 8.8% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 300204 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300204's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 547 | Wang Chao | www.staidson.com |
Staidson (Beijing) BioPharmaceuticals Co., Ltd. primarily engages in the research and development, production, and marketing of therapeutic drugs in China. The company offers protein drugs, including therapeutic monoclonal antibody drugs; gene therapy/cell therapy drugs; and chemical drugs. It principally offers its products under the fields of nervous system related, infectious, gastrointestinal, urinary system, and autoimmune diseases.
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Fundamentals Summary
| 300204 fundamental statistics | |
|---|---|
| Market cap | CN¥3.86b |
| Earnings (TTM) | -CN¥223.29m |
| Revenue (TTM) | CN¥350.71m |
11.0x
P/S Ratio-17.3x
P/E RatioIs 300204 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300204 income statement (TTM) | |
|---|---|
| Revenue | CN¥350.71m |
| Cost of Revenue | CN¥71.97m |
| Gross Profit | CN¥278.74m |
| Other Expenses | CN¥502.02m |
| Earnings | -CN¥223.29m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.47 |
| Gross Margin | 79.48% |
| Net Profit Margin | -63.67% |
| Debt/Equity Ratio | 0% |
How did 300204 perform over the long term?
See historical performance and comparison